Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2010 publications

Analysis of peripheral blood monocyte subsets in chronic myelomonocytic leukemia: a single-center study

Analysis of peripheral blood monocyte subsets in chronic myelomonocytic leukemia: a single-center study

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: December 03, 2025

The scaffold protein PRR14L links the PP2A-TACC3 axis to mitotic fidelity and sensitivity to MPS1 inhibition.

The scaffold protein PRR14L links the PP2A-TACC3 axis to mitotic fidelity and sensitivity to MPS1 inhibition.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Lupuslike Manifestations in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia.

Lupuslike Manifestations in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia.

Journal: JAMA dermatology
Published: November 19, 2025

Vasculitis associated with haematologic malignancies.

Vasculitis associated with haematologic malignancies.

Journal: Current opinion in rheumatology
Published: November 10, 2025

Erdheim-Chester Disease Masquerading as Leukemia: Outwitting the Need for Transplant.

Erdheim-Chester Disease Masquerading as Leukemia: Outwitting the Need for Transplant.

Journal: Cureus
Published: October 15, 2025

Optimizing outcomes in chronic myelomonocytic leukemia: sequencing approved therapies and new prospects.

Optimizing outcomes in chronic myelomonocytic leukemia: sequencing approved therapies and new prospects.

Journal: Expert opinion on pharmacotherapy
Published: October 03, 2025

Correspondence on: Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study.

Correspondence on: Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study.

Journal: Blood cancer journal
Published: September 16, 2025

Chronic myelomonocytic leukemia in the young (aged 50 years and younger): Divergent clinical and molecular characteristics from the elderly.

Chronic myelomonocytic leukemia in the young (aged 50 years and younger): Divergent clinical and molecular characteristics from the elderly.

Journal: Cancer
Published: September 15, 2025

Mixed Erdheim-Chester disease with thoraco-abdominal involvement.

Mixed Erdheim-Chester disease with thoraco-abdominal involvement.

Journal: Acta radiologica open
Published: September 15, 2025

Mutational Spectrum and Clinical Outcomes of Myelodysplastic/Myeloproliferative Neoplasms: A Single-Institution Study in Korea with Emphasis on U2AF1.

Mutational Spectrum and Clinical Outcomes of Myelodysplastic/Myeloproliferative Neoplasms: A Single-Institution Study in Korea with Emphasis on U2AF1.

Journal: Journal of clinical medicine
Published: September 13, 2025

Validation of BLAST and BLAST-Mol Risk Models in Chronic Myelomonocytic Leukemia: Mayo-Humanitas Collaborative Project Involving 1101 Patients.

Validation of BLAST and BLAST-Mol Risk Models in Chronic Myelomonocytic Leukemia: Mayo-Humanitas Collaborative Project Involving 1101 Patients.

Journal: American journal of hematology
Published: August 17, 2025

Colony-Stimulating Factor 3 Receptor Mutations and Variants in Hematological Malignancies.

Colony-Stimulating Factor 3 Receptor Mutations and Variants in Hematological Malignancies.

Journal: Cancers
Published: August 12, 2025
Showing 1-12 of 2,010

Last Updated: 01/07/2026